Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies

Cells. 2020 Dec 17;9(12):2709. doi: 10.3390/cells9122709.

Abstract

The treatment of tumors requires the induction of cell death. Radiotherapy, chemotherapy, and immunotherapy are administered to kill cancer cells; however, some cancer cells are resistant to these therapies. Therefore, effective treatments require various strategies for the induction of cell death. Regulated cell death (RCD) is systematically controlled by intracellular signaling proteins. Apoptosis and autophagy are types of RCD that are morphologically different from necrosis, while necroptosis, pyroptosis, and ferroptosis are morphologically similar to necrosis. Unlike necrosis, regulated necrotic cell death (RNCD) is caused by disruption of the plasma membrane under the control of specific proteins and induces tissue inflammation. Various types of RNCD, such as necroptosis, pyroptosis, and ferroptosis, have been used as therapeutic strategies against various tumor types. In this review, the mechanisms of necroptosis, pyroptosis, and ferroptosis are described in detail, and a potential effective treatment strategy to increase the anticancer effects on apoptosis- or autophagy-resistant tumor types through the induction of RNCD is suggested.

Keywords: apoptosis; autophagy; ferroptosis; necroptosis; necrosis; pyroptosis; therapy-resistant tumors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Autophagy
  • Ferroptosis
  • Humans
  • Inflammation / metabolism
  • Inflammation / pathology
  • Necroptosis
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Neoplasms / therapy
  • Pyroptosis
  • Regulated Cell Death* / drug effects

Substances

  • Antineoplastic Agents